Non-cystic fibrosis bronchiectasis: series of 89 patients

T. M. Alfaro, C. Robalo Cordeiro, M. Loureiro, M. Fontes Baganha (Coimbra, Portugal)

Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session: Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session type: E-Communication Session
Number: 273
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. M. Alfaro, C. Robalo Cordeiro, M. Loureiro, M. Fontes Baganha (Coimbra, Portugal). Non-cystic fibrosis bronchiectasis: series of 89 patients. Eur Respir J 2008; 32: Suppl. 52, 273

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Immuno-allertypes in non-cystic fibrosis  bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017


HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)
Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID
Year: 2021



Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001

The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019


Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017

The pulmonary microbiome in non-cystic fibrosis bronchiectasis.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015

Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Diagnosis and management of non-cystic fibrosis bronchiectasis in children
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018


Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018